Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (11-20 of 318) with videos related to

Pageof 32
Sort By:
Hepatology (Baltimore, Md.)|October 16, 2025
Reply: HBV DNA level of genuine immune-tolerant patientsTai-Chung Tseng, Tetsuya Hosaka, Hwai-I Yang, et al.
Annals of Surgical Oncology|July 14, 2026
Prognostic Benefit of Sequential Locoregional Interventions During First-Line Systemic Therapy for Hepatocellular Carcinoma: Insights from Interaction Analysis of Lenvatinib and Atezolizumab/BevacizumabJunichi Shindoh, Yusuke Kawamura, Tetsuya Hosaka, et al.
Journal of Medical Virology|May 7, 2014
Evolution of simeprevir-resistant variants over time by ultra-deep sequencing in HCV genotype 1bNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.
Journal of Medical Virology|February 7, 2015
Evolution of simeprevir-resistant variants in virological non-responders infected with HCV genotype 1bNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.
Journal of Medical Virology|July 18, 2013
A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis CTasuku Hara, Norio Akuta, Fumitaka Suzuki, et al.
Cureus|December 26, 2024
Clinical Impact and Significant Technical Points of Transarterial Chemoembolization (TACE) Using the Smaller Drug-Eluting Bead M1 (DC Bead M1™) for Hepatocellular Carcinoma: A Case SeriesYusuke Kawamura, Norio Akuta, Shigeki Yamamoto, et al.
Cureus|November 26, 2024
An Evaluation of the Most Convenient and Effective Procedure for Reducing the Loading Time of Epirubicin Into the Drug-Eluting Bead M1 (DC Bead M1™)Yusuke Kawamura, Norio Akuta, Shigeki Yamamoto, et al.
Journal of Hepatology|December 14, 2002
Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort studyNorio Akuta, Akihito Tsubota, Fumitaka Suzuki, et al.
Journal of Gastroenterology|October 22, 2003
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosisKenji Ikeda, Yasuji Arase, Masahiro Kobayashi, et al.
Intervirology|September 17, 2005
Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single centerKenji Ikeda, Yasuji Arase, Satoshi Saitoh, et al.
Pageof 32

Showing results (11-20 of 318) with videos related to

Sort By:
Pageof 32
Hepatology (Baltimore, Md.)|October 16, 2025
Reply: HBV DNA level of genuine immune-tolerant patientsTai-Chung Tseng, Tetsuya Hosaka, Hwai-I Yang, et al.
Annals of Surgical Oncology|July 14, 2026
Prognostic Benefit of Sequential Locoregional Interventions During First-Line Systemic Therapy for Hepatocellular Carcinoma: Insights from Interaction Analysis of Lenvatinib and Atezolizumab/BevacizumabJunichi Shindoh, Yusuke Kawamura, Tetsuya Hosaka, et al.
Journal of Medical Virology|May 7, 2014
Evolution of simeprevir-resistant variants over time by ultra-deep sequencing in HCV genotype 1bNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.
Journal of Medical Virology|February 7, 2015
Evolution of simeprevir-resistant variants in virological non-responders infected with HCV genotype 1bNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.
Journal of Medical Virology|July 18, 2013
A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis CTasuku Hara, Norio Akuta, Fumitaka Suzuki, et al.
Cureus|December 26, 2024
Clinical Impact and Significant Technical Points of Transarterial Chemoembolization (TACE) Using the Smaller Drug-Eluting Bead M1 (DC Bead M1™) for Hepatocellular Carcinoma: A Case SeriesYusuke Kawamura, Norio Akuta, Shigeki Yamamoto, et al.
Cureus|November 26, 2024
An Evaluation of the Most Convenient and Effective Procedure for Reducing the Loading Time of Epirubicin Into the Drug-Eluting Bead M1 (DC Bead M1™)Yusuke Kawamura, Norio Akuta, Shigeki Yamamoto, et al.
Journal of Hepatology|December 14, 2002
Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort studyNorio Akuta, Akihito Tsubota, Fumitaka Suzuki, et al.
Journal of Gastroenterology|October 22, 2003
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosisKenji Ikeda, Yasuji Arase, Masahiro Kobayashi, et al.
Intervirology|September 17, 2005
Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single centerKenji Ikeda, Yasuji Arase, Satoshi Saitoh, et al.
Pageof 32